Literature DB >> 6661266

Human and rat urinary metabolites of the antitumor drug Celiptium (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the "biooxidative alkylation" hypothesis.

B Monsarrat, M Maftouh, G Meunier, B Dugué, J Bernadou, J P Armand, C Picard-Fraire, B Meunier, C Paoletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6661266     DOI： 10.1016/0006-2952(83)90171-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Celiptium-induced nephrotoxicity and lipid peroxidation in rat renal cortex.

Authors:  C Dadoun; G Raguenez-Viotte
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Subcellular localization of celiptium-induced peroxidative damage in rat renal cortex.

Authors:  G Raguenez-Viotte; N Thomas; J P Fillastre
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Renal toxicity of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate in the Wistar rat.

Authors:  G Raguenez-Viotte; C Dadoun; P Buchet; T Ducastelle; J P Fillastre
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

4.  Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.

Authors:  J Bernadou; B Monsarrat; H Roche; J P Armand; C Paoletti; B Meunier
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.